American Society of Hematology

Fig. 9.

$Fig. 9. Neutralizing activity of antichemokine Abs in cocultures of unfractionated PBMCs from HIV-1 (PR-5) and HTLV-II (PR-2) monoinfected patients. / PBMCs from the 2 individuals were cocultivated in the same chamber but separated by a semipermeable membrane up to 30 days in the presence or absence of antichemokine Abs (2 μg/mL each) added either individually or in combination.$

Neutralizing activity of antichemokine Abs in cocultures of unfractionated PBMCs from HIV-1 (PR-5) and HTLV-II (PR-2) monoinfected patients.

PBMCs from the 2 individuals were cocultivated in the same chamber but separated by a semipermeable membrane up to 30 days in the presence or absence of antichemokine Abs (2 μg/mL each) added either individually or in combination.

This Feature Is Available To Subscribers Only